U.S. and China regulators have now cleared Sineugene Therapeutics' ALS gene therapy SNUG01 for clinical trials.

United States of America's Miss Ohio 2025 Tamera Carter will join hundreds of walkers and community partners on Sept. 14 to ...

As the professional title suggests, speech-language pathologists assess and treat more than just speech disabilities. They ...

Sometimes, an illness creates a sudden need to find a Plan B. Thanks to Jeff Bezos, you can now become a landlord for as ...

Many people will never know the last time they will do certain things in life. Even though he navigates sometimes trying days ...

Sandra Bullock made a rare reference to her late longtime partner Bryan Randall's private battle with ALS in a new interview, ...

Scientists have created a lifelike model of Amyotrophic Lateral Sclerosis (ALS), a type of motor neuron disease, using cells ...

MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...

This year's ALS Nexus conference allowed the community to connect with each other, celebrate recent advances, and share hope ...

A compound normally associated with red blood cells may also play a game-changing antioxidant role in the brain, a study has ...

Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...